Cargando…
miR-105 Promotes the Progression and Predicts the Prognosis for Oral Squamous Cell Carcinoma (OSCC)
BACKGROUND: miRNA-105 has been reported in a vast number of malignancies, including hepatocellular carcinoma and colorectal, esophageal, breast and non-small lung cancers. Still, the biological role of miR-105 remains mostly uncovered in oral squamous cell carcinoma (OSCC). METHODS: miR-105 expressi...
Autores principales: | Zhang, Hong-Yu, Ma, Jian-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667180/ https://www.ncbi.nlm.nih.gov/pubmed/33204160 http://dx.doi.org/10.2147/CMAR.S262442 |
Ejemplares similares
-
Early Diagnosis of Oral Squamous Cell Carcinoma (OSCC) by miR-138 and miR-424-5p Expression as a Cancer Marker
por: Bolandparva, Farzaneh, et al.
Publicado: (2021) -
MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6
por: Shao, Yuan, et al.
Publicado: (2013) -
Secreted protein markers in oral squamous cell carcinoma (OSCC)
por: Mumtaz, Madiha, et al.
Publicado: (2022) -
Methylation of TGM-3 Promoter and Its Association with Oral Squamous Cell Carcinoma (OSCC)
por: Shojaeian, Sorour, et al.
Publicado: (2021) -
Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma
por: Shi, Jianbo, et al.
Publicado: (2019)